Science Explorer Back to mapMap
Discussion
Company · Medford · United States

Glycosyn (United States)

glycosynllc.comROR OpenAlex
Research works
8
▼ 31% vs 2018-21
Citations
138
17.8 per fractional work
Top-10% rate
10.0%
all institutions 10.0%
Open access
5%
world 40%
International
24%
world 18%
Glycosyn (United States)

Not ranked overall: Glycosyn (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Glycosyn (United States) work in?

In all years, 49% of research at Glycosyn (United States) is in Life Sciences, 28% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (31%), Medicine (15%), Engineering (13%). It does 1.6× the world's share of Life Sciences.

Life Sciences: 4 fractional works · 49.4% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 30.7% of its workMolecular Biology: 2 fractional works · 20.7% of its workGenetics: 0 fractional works · 5.0% of its workCell Biology: 0 fractional works · 4.3% of its workBiochemistry: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 1 fractional works · 10.1% of its workInsect Science: 0 fractional works · 6.4% of its workPlant Science: 0 fractional works · 2.4% of its workFood Science: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 1 fractional works · 8.6% of its workImmunology: 1 fractional works · 8.6% of its workPhysical Sciences: 2 fractional works · 28.0% of its workEngineering: 1 fractional works · 12.9% of its workControl and Systems Engineering: 1 fractional works · 12.9% of its workChemistry: 1 fractional works · 10.8% of its workOrganic Chemistry: 1 fractional works · 10.8% of its workMaterials Science: 0 fractional works · 4.3% of its workMaterials Chemistry: 0 fractional works · 4.3% of its workHealth Sciences: 2 fractional works · 22.7% of its workMedicine: 1 fractional works · 15.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 9.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 2.2% of its workHematology: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 1.0% of its workPhysiology: 0 fractional works · 0.9% of its workImmunology and Allergy: 0 fractional works · 0.8% of its workNursing: 1 fractional works · 7.5% of its workNutrition and Dietetics: 1 fractional works · 7.5% of its workALL ITS WORKGlycosyn (UnitedStates)8fractional works, all years
Life Sciences49%Physical Sciences28%Health Sciences23%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 8 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology230.7%
    2. Agricultural and Biological Sciences110.1%
    3. Immunology and Microbiology18.6%
    1. Engineering112.9%
    2. Chemistry110.8%
    3. Materials Science04.3%
    1. Medicine115.2%
    2. Nursing17.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Glycosyn (United States)?

The most cited paper from Glycosyn (United States) is "The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota" (Zhuoteng Yu, Ceng Chen, David E. Kling et al., 2012), with 256 citations. Next come "Corn silk crude polysaccharide exerts anti-pancreatic cancer activity by blocking the EGFR/PI3K/AKT/CREB signaling pathway" (40) and "Studies on the Structure of the Complex of the Boron Neutron Capture Therapy Drug, L‐p‐Boronophenylalanine, with Fructose and Related Carbohydrates: Chemical and 13C NMR evidence for the β‐D‐Fructofuranose 2,3,6‐(p‐Phenylalanylorthoboronate) Structure" (37).

Most cited papers
#PaperReleasedCitations
1 The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota Zhuoteng Yu, Ceng Chen, David E. Kling et al. · Glycobiology Open access Oct 2012 256
2 Corn silk crude polysaccharide exerts anti-pancreatic cancer activity by blocking the EGFR/PI3K/AKT/CREB signaling pathway Hong Tao, Xia Chen, Zhenyun Du et al. · Food & Function 2020 40
3 Studies on the Structure of the Complex of the Boron Neutron Capture Therapy Drug, L‐p‐Boronophenylalanine, with Fructose and Related Carbohydrates: Chemical and 13C NMR evidence for the β‐D‐Fructofuranose 2,3,6‐(p‐Phenylalanylorthoboronate) Structure Brian K. Shull, David E. Spielvogel, Gerald Head et al. · Journal of Pharmaceutical Sciences Feb 2000 37
4 Evidence for spontaneous, reversible paracyclophane formation. Aprotic solution structure of the boron neutron capture therapy drug, L-p-boronophenylalanine Brian K. Shull, David E. Spielvogel, Ramesh Gopalaswamy et al. · Journal of the Chemical Society Perkin Transactions 2 2000 28
5 Integration of Cell-to-Cell Signals in Soil Bacterial Communities Max Teplitski, Massimo Merighi, Mengsheng Gao et al. · Soil biology Book chapter 20 Sep 2010 6
All 6 most cited papers, with filters and sorting

Which research topics does Glycosyn (United States) publish most on?

By volume in 2022-now: Pluripotent Stem Cells Research, Animal Genetics and Reproduction and Reproductive Biology and Fertility.

Pluripotent Stem Cells R…0Pluripotent Stem Cells Research: 0 fractional worksAnimal Genetics and Repr…0Animal Genetics and Reproduction: 0 fractional worksReproductive Biology and…0Reproductive Biology and Fertility: 0 fractional works
Molecular BiologyGeneticsPublic Health, Environmental and Occupational Health

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pluripotent Stem Cells Research Molecular Biology 0 works
  2. 2 Animal Genetics and Reproduction Genetics 0 works
  3. 3 Reproductive Biology and Fertility Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available5.1%not open94.9%

World: 40% of research is openly available.

with international co-authors23.7%domestic only76.3%

World: 18% is written across borders.

How has Glycosyn (United States)'s research output changed?

Output in 2022-2025 was 31% lower than in 2018-2021.

199520002005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Glycosyn (United States) as a percentage of every work published that year, 0.0000027% in 2021.

0.000050%0.00010%0.00015%Glycosyn (United States)0.0000090% in 2024200020102020

Fractional works of Glycosyn (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Medford

All research institutions in Medford

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Glycosyn (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.